Open access
2,762
Views
2
CrossRef citations to date
0
Altmetric
Research Articles
Relationship of binding-site occupancy, transthyretin stabilisation and disease modification in patients with tafamidis-treated transthyretin amyloid cardiomyopathy
David A. Tessa Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc, Cambridge, MA, USAView further author information
, Tristan S. Maurera Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc, Cambridge, MA, USAView further author information
, Zhenhong Lia Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc, Cambridge, MA, USAView further author information
, Christine Bulawab Rare Disease Research Unit, Pfizer Inc., Cambridge, MA, USAView further author information
, James Flemingb Rare Disease Research Unit, Pfizer Inc., Cambridge, MA, USAView further author information
& Amy T. Moodya Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer Inc, Cambridge, MA, USACorrespondence[email protected]
View further author information
View further author information
Pages 208-219
|
Received 03 Jul 2022, Accepted 06 Nov 2022, Published online: 18 Nov 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.